We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vasopressin Is Best Drug for Some Cases of Cardiac Arrest

By HospiMedica staff writers
Posted on 21 Jan 2004
A study has found that in certain patients with cardiac arrest, vasopressin is better than adrenaline, the standard emergency treatment. More...
The results were reported in the January 8, 2004, issue of The New England Journal of Medicine.

The study involved 1,186 people with cardiac arrest. The overall survival rate for the two drugs was the same. However, in patients with asystole, in which pulse and electrical activity have ceased, 12 patients out of 257 taking vasopressin survived, while only four of 262 taking adrenaline survived. Almost two-thirds of all patients in the study required more than two doses of medicine to restart their hearts. Of these, almost 23 of 369 survived who were given vasopressin first, but only six of the 355 survived who were given adrenaline first. The study did not include patients revived by electrical shocks but did include patients for whom defibrillation failed or was inappropriate. Patients in the study also received emergency treatment, including rescue breathing and chest compressions.

The study was conducted by Dr. Volker Wenzel, University of Innsbruck (Austria). According to Dr.Wenzel, vasopressin shifts the flow of blood away from the skin, legs, abdomen, and muscles, and toward the brain and heart. He reported that he now gives both drugs to all adults with cardiac arrest.




Related Links:
U. of Innsbruck

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.